Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting peroxiredoxin 1 impairs growth of breast cancer cells and potently sensitises these cells to prooxidant agents
Małgorzata Bajor, Agata O. Zych, Agnieszka Graczyk‐Jarzynka, et al.
British Journal of Cancer (2018) Vol. 119, Iss. 7, pp. 873-884
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
Klaudia Jomová, Renáta Raptová, Suliman Yousef Alomar, et al.
Archives of Toxicology (2023) Vol. 97, Iss. 10, pp. 2499-2574
Open Access | Times Cited: 964
Antioxidant Therapy in Cancer: Rationale and Progress
Maochao Luo, Li Zhou, Zhao Huang, et al.
Antioxidants (2022) Vol. 11, Iss. 6, pp. 1128-1128
Open Access | Times Cited: 114
Ainsliadimer A induces ROS-mediated apoptosis in colorectal cancer cells via directly targeting peroxiredoxin 1 and 2
Chao Lv, Yun Huang, Qun Wang, et al.
Cell chemical biology (2023) Vol. 30, Iss. 3, pp. 295-307.e5
Open Access | Times Cited: 47
The rheumatoid arthritis drug Auranofin targets peroxiredoxin 1 and peroxiredoxin 2 to trigger ROS-endoplasmic reticulum stress axis-mediated cell death and cytoprotective autophagy
Wenyue Yang, Zhou Zhu, Chaohua Zhou, et al.
Free Radical Biology and Medicine (2025)
Closed Access | Times Cited: 2
Antioxidants for the Treatment of Breast Cancer: Are We There Yet?
Carmen Griñán‐Lisón, José L. Blaya-Cánovas, Araceli López-Tejada, et al.
Antioxidants (2021) Vol. 10, Iss. 2, pp. 205-205
Open Access | Times Cited: 77
Radiation induces IRAK1 expression to promote radioresistance by suppressing autophagic cell death via decreasing the ubiquitination of PRDX1 in glioma cells
Jing Li, Yuchen Sun, Xu Zhao, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 4
Open Access | Times Cited: 22
A metabolic map of the DNA damage response identifies PRDX1 in the control of nuclear ROS scavenging and aspartate availability
Amandine Moretton, Savvas Kourtis, Antoni Gañez Zapater, et al.
Molecular Systems Biology (2023) Vol. 19, Iss. 7
Open Access | Times Cited: 21
Dual role of PRDX1 in redox-regulation and tumorigenesis: Past and future
Xin–Yuan Guan, Yiyin Ruan, Xiaoxia Che, et al.
Free Radical Biology and Medicine (2023) Vol. 210, pp. 120-129
Closed Access | Times Cited: 17
MicroRNA and Oxidative Stress Interplay in the Context of Breast Cancer Pathogenesis
Giulia Cosentino, Ilaria Plantamura, Alessandra Cataldo, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 20, pp. 5143-5143
Open Access | Times Cited: 45
The Immune Landscape of Breast Cancer: Strategies for Overcoming Immunotherapy Resistance
Kuba Retecki, Milena Seweryn, Agnieszka Graczyk‐Jarzynka, et al.
Cancers (2021) Vol. 13, Iss. 23, pp. 6012-6012
Open Access | Times Cited: 39
Proteomics and its applications in breast cancer.
Anca-Narcisa Neagu, Danielle Whitham, Emma Buonanno, et al.
PubMed (2021) Vol. 11, Iss. 9, pp. 4006-4049
Closed Access | Times Cited: 38
The Role of Peroxiredoxins in Cancer Development
Pratik Thapa, Hong Jiang, Na Ding, et al.
Biology (2023) Vol. 12, Iss. 5, pp. 666-666
Open Access | Times Cited: 16
Frenolicin B Targets Peroxiredoxin 1 and Glutaredoxin 3 to Trigger ROS/4E-BP1-Mediated Antitumor Effects
Qing Ye, Yinan Zhang, Yanan Cao, et al.
Cell chemical biology (2019) Vol. 26, Iss. 3, pp. 366-377.e12
Open Access | Times Cited: 38
Redox modifications of cysteine-containing proteins, cell cycle arrest and translation inhibition: Involvement in vitamin C-induced breast cancer cell death
Nadine El Banna, Elie Hatem, Amélie Heneman-Masurel, et al.
Redox Biology (2019) Vol. 26, pp. 101290-101290
Open Access | Times Cited: 38
Exploring the key communicator role of exosomes in cancer microenvironment through proteomics
Hui-Su Kim, Dong Wook Kim, Je‐Yoel Cho
Proteome Science (2019) Vol. 17, Iss. 1
Open Access | Times Cited: 37
Antioxidants from different citrus peels provide protection against cancer
Nouf K. Alaqeel
Brazilian Journal of Biology (2023) Vol. 84
Open Access | Times Cited: 12
Hepatocellular carcinoma cells downregulate NADH:Ubiquinone Oxidoreductase Subunit B3 to maintain reactive oxygen species homeostasis
Zhendong Zhang, Qianwei Zhao, Zexuan Wang, et al.
Hepatology Communications (2024) Vol. 8, Iss. 3
Open Access | Times Cited: 4
Tomentosin Displays Anti-Carcinogenic Effect in Human Osteosarcoma MG-63 Cells via the Induction of Intracellular Reactive Oxygen Species
Chang Min Lee, Jongsung Lee, Myeong Jin Nam, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 6, pp. 1508-1508
Open Access | Times Cited: 35
Harnessing altered oxidative metabolism in cancer by augmented prooxidant therapy
Małgorzata Firczuk, Małgorzata Bajor, Agnieszka Graczyk‐Jarzynka, et al.
Cancer Letters (2019) Vol. 471, pp. 1-11
Closed Access | Times Cited: 35
<p>The Prognosis Of Peroxiredoxin Family In Breast Cancer</p>
Gang Wang, Wan-Chao Zhong, Yihui Bi, et al.
Cancer Management and Research (2019) Vol. Volume 11, pp. 9685-9699
Open Access | Times Cited: 30
Cell Progression and Survival Functions of Enzymes Secreted in Extracellular Vesicles Associated with Breast and Prostate Cancers
Cosmos Ifeanyi Onyiba, Namita Kumar, Christopher J. Scarlett, et al.
Cells (2025) Vol. 14, Iss. 7, pp. 468-468
Open Access
PRDX1 protects ATM from arsenite-induced proteotoxicity and maintains its stability during DNA damage signaling
Reem Ali, Mashael Algethami, Amera Sheha, et al.
Oncotarget (2025) Vol. 16, Iss. 1, pp. 362-378
Open Access
Comprehensive analysis of peroxiredoxins expression profiles and prognostic values in breast cancer
Jie Mei, Leiyu Hao, Xiaorui Liu, et al.
Biomarker Research (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 28
Triple Combination of Ascorbate, Menadione and the Inhibition of Peroxiredoxin-1 Produces Synergistic Cytotoxic Effects in Triple-Negative Breast Cancer Cells
Małgorzata Bajor, Agnieszka Graczyk‐Jarzynka, Katsiaryna Marhelava, et al.
Antioxidants (2020) Vol. 9, Iss. 4, pp. 320-320
Open Access | Times Cited: 26
Peroxiredoxin 1 is essential for natamycin-triggered apoptosis and protective autophagy in hepatocellular carcinoma
Yao An, Jingwen Jiang, Li Zhou, et al.
Cancer Letters (2021) Vol. 521, pp. 210-223
Closed Access | Times Cited: 22
Page 1 - Next Page

Scroll to top